US Broker Ratings

GSK plc (GSK) Stock Analysis: Healthcare Giant Offers 20.99% Potential Upside

For individual investors eyeing opportunities in the healthcare sector, GSK plc (GSK) presents a compelling case. With a market capitalization of $98.62 billion, this UK-based pharmaceutical..

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a 23.90% Upside Potential in the Healthcare Sector

Option Care Health, Inc. (NASDAQ: OPCH), a formidable player in the healthcare sector, specifically in medical care facilities, presents an intriguing investment opportunity with a notable..

Guardant Health, Inc. (GH) Stock Analysis: Navigating the Precision Oncology Frontier with a 10.80% Potential Upside

Guardant Health, Inc. (NASDAQ: GH), a prominent player in the diagnostics and research sector of the healthcare industry, is capturing investor attention with its cutting-edge precision..

DaVita Inc. (DVA) Stock Analysis: Healthcare Powerhouse with 23% Upside Potential

DaVita Inc. (NYSE: DVA), a leading player in the healthcare sector, specifically within the medical care facilities industry, is drawing investor attention with its robust performance..

Glaukos Corporation (GKOS) Stock Analysis: Unlocking 28.66% Potential Upside in the Medical Device Sector

Glaukos Corporation (NYSE: GKOS) is capturing the attention of investors with its significant potential upside of 28.66%, presenting an intriguing opportunity in the healthcare sector. Specializing..

McKesson Corporation (MCK) Stock Analysis: Healthcare Leader with 13% Potential Upside

McKesson Corporation (NYSE: MCK), a powerhouse in the healthcare sector, stands out as a significant player in the medical distribution industry. With a market capitalization of..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Unveiling Growth Potential with a 7.97% Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is a prominent player in the biotechnology sector, with a robust market capitalization of $81.13 billion. Founded in 1988 and headquartered..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Healthcare Growth with a 25.78% Upside Potential

Teleflex Incorporated (NYSE: TFX), a key player in the healthcare sector, is capturing the attention of investors with its innovative medical devices. With a market capitalization..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unpacking a 72% Potential Upside in Biotech

For investors seeking opportunities in the healthcare sector, Telix Pharmaceuticals Limited (ASX: TLX) presents a compelling case with its promising pipeline in the biotechnology industry. Headquartered..

Elevance Health, Inc. (ELV) Stock Analysis: A Promising 13.96% Potential Upside for Investors

Elevance Health, Inc. (NYSE: ELV) stands as a prominent player in the healthcare plans industry with a significant market capitalization of $85.9 billion. As an integral..

Waystar Holding Corp. (WAY) Stock Analysis: Capturing a 36% Potential Upside in Healthcare Innovation

Waystar Holding Corp. (NASDAQ: WAY), a key player in the healthcare information services sector, is making waves with its innovative cloud-based software solutions aimed at streamlining..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a 22% Potential Upside in the Medical Devices Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the medical devices industry, offers investors a compelling opportunity for growth. With its extensive portfolio catering..

argenx SE (ARGX) Stock Analysis: Understanding the 23% Potential Upside

Investors with a keen eye on the biotechnology sector should pay close attention to argenx SE (NASDAQ: ARGX), a compelling player in the healthcare industry with..

Tenet Healthcare Corporation (THC) Stock Analysis: Strong Buy Ratings and Nearly 10% Upside Potential

Tenet Healthcare Corporation (NYSE: THC) stands as a formidable player within the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of..

BridgeBio Pharma, Inc. (BBIO): Investor Outlook Suggests 66% Upside Potential Amidst Strong Analyst Ratings

BridgeBio Pharma, Inc. (NASDAQ: BBIO) stands out in the biotechnology sector, boasting a market capitalization of $12.82 billion and a robust pipeline targeting genetic diseases. With..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating Investor Sentiment with a 13.71% Potential Downside

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands as a formidable entity in the healthcare sector, primarily operating within the medical devices industry. With a market capitalization of..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a 15.95% Potential Upside

For investors seeking opportunities in the healthcare sector, Merit Medical Systems, Inc. (NASDAQ: MMSI) presents an intriguing prospect. This Utah-based company operates within the Medical Instruments..

Novo Nordisk A/S (NVO) Investor Outlook: Exploring a 19.41% Potential Upside

Novo Nordisk A/S (NYSE: NVO), a leading global healthcare company headquartered in Denmark, is garnering significant attention from investors, driven by its robust market position and..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating the Healthcare AI Frontier Amidst a Volatile Valuation Landscape

Tempus AI, Inc. (NASDAQ: TEM), a pioneering force in healthcare technology, operates at the intersection of artificial intelligence and healthcare services. With a market capitalization of..

Regencell Bioscience Holdings L (RGC) Stock Analysis: Navigating the Volatility in TCM Innovations

Regencell Bioscience Holdings Limited (NASDAQ: RGC) stands out in the healthcare sector as a pioneer in Traditional Chinese Medicine (TCM) bioscience. Headquartered in Causeway Bay, Hong..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds